Biocon Pharma Company Profile
What is the competitive landscape for BIOCON PHARMA
BIOCON PHARMA has thirty-one approved drugs.
There are six tentative approvals on BIOCON PHARMA drugs.
Summary for Biocon Pharma
| US Patents: | 0 |
| Tradenames: | 27 |
| Ingredients: | 27 |
| NDAs: | 31 |
| PTAB Cases with Biocon Pharma as petitioner: | See PTAB cases with Biocon Pharma as petitioner |
Drugs and US Patents for Biocon Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biocon Pharma | SIMVASTATIN | simvastatin | TABLET;ORAL | 078034-004 | Dec 20, 2006 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Biocon Pharma | EVEROLIMUS | everolimus | TABLET, FOR SUSPENSION;ORAL | 217216-001 | Jan 9, 2026 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Biocon Pharma | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 207752-002 | Oct 31, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
